UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000003620
Receipt No. R000004362
Official scientific title of the study Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study
Date of disclosure of the study information 2010/05/17
Last modified on 2018/12/01 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study
Title of the study (Brief title) Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study
Region
Japan

Condition
Condition Acute Coronary Syndrome
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This is an exploratory study aiming to elucidate the mechanism underlying plaque stabilization of statin treatment using Optical Coherence Tomography
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes For the plaques evaluated by OCT, what are the differences in plaque-stabilizing effects of atorvastatin in plaques with different characteristics (fibrous cap thickness)?
Key secondary outcomes 1. Are LDL-C and fibrous-cap thickness inversely-correlated?
2. Are plaque volume and fibrous-cap thickness inversely-correlated?
3. Does atorvastatin suppress new plaque formation?

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -but assessor(s) are blinded
Control No treatment
Stratification
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 10 to 20 mg pitavastatin daily started within 24 hours of PCI to maintain LDL-cho level less than 70mg/dl
Interventions/Control_2 Control
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria 1. Patients with acute coronary syndrome (including ST-segment elevation acute myocardial infarction, non-ST-segment elevation myocardial infarction and unstable angina).
2. Patients who have at least one critical stenosis involving 75% or more of the stenosis
3. LDL-cho level between 100mg/dl and 180mg/dl
4. Patients providing written consent for participation in this clinical trial on their own volition after receiving a thorough explanation about the study
Key exclusion criteria 1. Patients who will undergo elective percutaneous coronary intervention,
2. Patients who received thrombolytic therapy
3. Previous statin treatment
4. Severe left ventricular dysfunction (Ejection fraction <40% by echocardiogram),
5. Uncontrolled severe diabetes mellitus (HbA1c >12.0%).
Target sample size 50

Research contact person
Name of lead principal investigator Tohru Masuyama
Organization Hyogo College of Medicine
Division name Cardiovascular Division
Address 1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 6638501 JAPAN
TEL 0798-45-6553
Email

Public contact
Name of contact person Kenichi Fujii
Organization Hyogo College of Medicine
Division name Cardiovascular Division
Address 1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 6638501 JAPAN
TEL 0798-45-6553
Homepage URL
Email kfujii@hyo-med.ac.jp

Sponsor
Institute Hyogo College of Medicine
Cardiovascular Division
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2010 Year 05 Month 17 Day

Progress
Recruitment status Completed
Date of protocol fixation
2008 Year 05 Month 01 Day
Anticipated trial start date
2008 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2010 Year 05 Month 16 Day
Last modified on
2018 Year 12 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004362